Southmedic was founded in 1983 and is based in Canada. It produces qualified medical consumables, surgical materials, vaporizer, face and eye shields in modern production facilities. In addition to FDA, CE, ISO quality certificates, it has certified Class 100,000 clean rooms, modern injection molding machines up to 300 tons and 3D model design units.
The patented OxyMask ™ product group, which consists of oxygen masks and nasal cannula, does not contain the disadvantages of traditional face masks, prioritizes patient safety and provides 24% to 90% FIO2. Products in this group allow ETCO2 measurements to be made during oxygen delivery. In addition, owing to the special open design of the mask, communication between the patient and the healthcare provider can be provided easily. In oxygen therapy, OxyMask ™ is recognized worldwide as a widespread and innovative product.
Southmedic manages its products for respiratory support, surgery, anesthesia and central sterilization by its own sales and technical team in Canada, and offers them to use through its distribution network operating in more than 60 countries.